CN101983652A - Traditional Chinese medicine for treating scapulohumeral periarthritis - Google Patents

Traditional Chinese medicine for treating scapulohumeral periarthritis Download PDF

Info

Publication number
CN101983652A
CN101983652A CN2010105037593A CN201010503759A CN101983652A CN 101983652 A CN101983652 A CN 101983652A CN 2010105037593 A CN2010105037593 A CN 2010105037593A CN 201010503759 A CN201010503759 A CN 201010503759A CN 101983652 A CN101983652 A CN 101983652A
Authority
CN
China
Prior art keywords
grams
medicine
scapulohumeral periarthritis
chinese medicine
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN2010105037593A
Other languages
Chinese (zh)
Inventor
黄岭
Original Assignee
黄岭
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 黄岭 filed Critical 黄岭
Priority to CN2010105037593A priority Critical patent/CN101983652A/en
Publication of CN101983652A publication Critical patent/CN101983652A/en
Pending legal-status Critical Current

Links

Abstract

The invention relates to a traditional Chinese medicine for treating scapulohumeral periarthritis. The component proportion of the medicament is as follows: safflower 30g, Chinese angelica 30g, vegetable sponge of luffa 30g, rhizoma anemones raddeanae 50g, eucommia 40g, notopterygium root 40g, frankincense 25g and myrrh 25g. The accuracy of the ratio of the fixed dosages is plus or minus 10% of the above components. The components are soaked for 30mins in rootless water and crushed to powder after being fished out and dried in the shade. Each set of the medicament is mixed with 150 g of spirits (60% alcohol).The traditional Chinese medicine of the invention has the advantages of pain relieving, no recurrence after return visits and obvious effect on treating scapulohumeral periarthritis and is free of any toxic or side effect.

Description

A kind of Chinese medicine for the treatment of scapulohumeral periarthritis
Technical field
The present invention relates to a kind of medicine for the treatment of scapulohumeral periarthritis, especially a kind of Chinese medicine for the treatment of scapulohumeral periarthritis.
Background technology
At present, scapulohumeral periarthritis produces pain gradually with shoulder, night is for very, increase the weight of gradually, the shoulder joint movable function is limited and increase the weight of day by day, alleviates the capsula articularis humeri of main performance and the chronic specificity inflammation of ligament, tendon and synovial bursa on every side thereof after causing necessarily to a certain degree gradually, present medicine not only curative effect is not ideal enough, and the toxic and side effects of how influential health occurs.
Summary of the invention
For existing some, the medicine that solves present treatment scapulohumeral periarthritis treats unfavorable problem, the invention provides a kind of Chinese medicine for the treatment of scapulohumeral periarthritis, it is remarkable that the Chinese medicine of this treatment scapulohumeral periarthritis can be treated the scapulohumeral periarthritis effect, makes pain disappear, do not recur after the further consultation, without any side effects.
Concrete proportioning of the present invention is: Flos Carthami 30 gram, Radix Angelicae Sinensis 30 grams, Retinervus Luffae Fructus 30 grams, Rhizoma Anemones Raddeanae 50 grams, the Cortex Eucommiae 40 grams, Rhizoma Et Radix Notopterygii 40 grams, Olibanum 25 grams, Myrrha 25 grams, the degree of accuracy of the dose of this medicine be each medicine ± 10%.
The pharmacology of this medicated cushion is: Flos Carthami, Radix Angelicae Sinensis, Retinervus Luffae Fructus, Rhizoma Anemones Raddeanae, the Cortex Eucommiae, Rhizoma Et Radix Notopterygii all have the effect of curing rheumatism; Olibanum, Myrrha have the effect of reducing swelling and alleviating pain.
Preparing process of the present invention: get the quantitative medicine of Flos Carthami, Radix Angelicae Sinensis, Retinervus Luffae Fructus, Rhizoma Anemones Raddeanae, the Cortex Eucommiae, Rhizoma Et Radix Notopterygii, Olibanum and Myrrha, pull out after 30 minutes with the 1500 gram immersions of unrooted water, pulverizing after medicine is dried in the shade is powdery, and every pair of medicinal 60 degree Chinese liquor, 150 grams are mixed thoroughly and got final product.
Administrated method of the present invention is: above-mentioned patent medicine spread on the sore place, and blood circulation promoting and blood stasis dispelling, 3-4 hour every day, every pair of medicine used 4-5 days, and 3 attached medicines are a course of treatment.
The invention has the beneficial effects as follows: the treatment by Chinese herbs scapulohumeral periarthritis effect of this treatment scapulohumeral periarthritis is remarkable, makes pain disappear, and does not recur after the further consultation, and is without any side effects.
The specific embodiment
Through over 2 years, the clinical practice to 100 example treatment scapulohumeral periarthritis patients has obtained curative effect preferably, and total effective rate reaches 95%, and details are as follows for relevant clinical treatment situation
1. patient profile: select projects such as medical history, the state of an illness, age, sex and original therapy method.
2. patient originates: with general hospital patient and professional OH patient.
3. case is gone into the group standard, and according to the clinical manifestation and the pathological characters branch of treatment scapulohumeral periarthritis disease, sex, age are not limit, and the course of disease is more than 6 months; Get rid of serious physical disease; Inactive various other a kind of Chinese medicine and therapeutic modalities for the treatment of scapulohumeral periarthritis before the treatment.
4. preparing process: get the quantitative medicine of Flos Carthami, Radix Angelicae Sinensis, Retinervus Luffae Fructus, Rhizoma Anemones Raddeanae, the Cortex Eucommiae, Rhizoma Et Radix Notopterygii, Olibanum and Myrrha, soak with unrooted water 1500 grams and pull out after 30 minutes, the medicine back of being dried in the shade is pulverized and is powdery, and every pair of medicinal 60 degree Chinese liquor, 150 grams are mixed thoroughly and got final product.
5. administrated method: above-mentioned patent medicine is spread on the sore place, blood circulation promoting and blood stasis dispelling, 3-4 hour every day, every pair of medicine used 4-5 days, and 3 attached medicines are a course of treatment.
6. efficacy evaluation: 1. recovery from illness: scapulohumeral periarthritis transference cure, thoroughly recovery from illness; 2. remarkable: as more than curing later six months recurrence not to be arranged; 3. effective: morbidity significantly reduces; 4. invalid: change not quite before and after the treatment, or once taking a turn for the better, after return to symptom before the treatment again.
7. efficacy analysis:
1. sex: according to going into the group standard, we treat scapulohumeral periarthritis disease patient 100 examples altogether, male's 60 examples (60%) wherein, women's 40 examples (40%).
2. the course of disease: 6 months~1 year is 50 examples, and 1 year~2 years is 30 examples, is 20 examples more than 2 years.
3. age group: 25~30 years old 10 example, 31~40 years old 20 example, 41~50 years old 20 example, 51~60 years old 25 example, 25 examples more than 60 years old.
4. prepare the dose scheme for first kind: Flos Carthami 27 restrains, Radix Angelicae Sinensis 27 restrains, Retinervus Luffae Fructus 27 restrains, Rhizoma Anemones Raddeanae 45 restrains, the Cortex Eucommiae 36 restrains, Rhizoma Et Radix Notopterygii 36 restrains, Olibanum 22.5 restrains, Myrrha 22.5 restrains.
The efficacy analysis of this scheme, administration time are 1~2 course of treatment.
Patient's type Recovery from illness Significantly Effectively Invalid
Patients with mild 50 examples 40 7 2 1
Moderate patient's 35 examples 30 2 2 1
Severe patient 15 examples 10 1 1 3
The scheme of second kind of preparation dose: Flos Carthami 30 grams, Radix Angelicae Sinensis 30 grams, Retinervus Luffae Fructus 30 grams, Rhizoma Anemones Raddeanae 50 grams, the Cortex Eucommiae 40 grams, Rhizoma Et Radix Notopterygii 40 grams, Olibanum 25 grams, Myrrha 25 grams.
The efficacy analysis of this scheme, administration time are 1~2 course of treatment.
Patient's type Recovery from illness Significantly Effectively Invalid
Patients with mild 45 examples 35 8 1 1
Moderate patient's 40 examples 35 3 1 1
Severe patient 15 examples 10 3 1 1
The scheme of the third preparation dose: Flos Carthami 33 grams, Radix Angelicae Sinensis 33 grams, Retinervus Luffae Fructus 33 grams, Rhizoma Anemones Raddeanae 55 grams, the Cortex Eucommiae 44 grams, Rhizoma Et Radix Notopterygii 44 grams, Olibanum 27.5 grams, Myrrha 27.5 grams.
The efficacy analysis of this scheme, administration time are 1~2 course of treatment.
Patient's type Recovery from illness Significantly Effectively Invalid
Patients with mild 50 examples 40 8 1 1
Moderate patient's 40 examples 35 3 1 1
Severe patient 10 examples 7 1 1 1
By Drug therapy scapulohumeral periarthritis disease of the present invention, received satisfied curative effect.The symptom of this diseases of whole body is a lot, and this clinical experiment is divided into " slightly ", " moderate " and " seriously " several types according to clinical characters, and this clinical experiment is to carry out jointly at general hospital and special outpatient clinic.
Before this group case treatment, during most of patients was carried out, the treatment of doctor trained in Western medicine mode, but all do not obtain curative effect preferably, especially Western medicine is for oral administration, and side effect is bigger, and human body is caused very major injury, most of patients all are unwilling to accept to take western medicine for a long time, and drug withdrawal voluntarily.In the process of taking Chinese medicine medicine of the present invention, must not take Western medicine and use injection, or other treats this sick medicine.
It is remarkable that the Chinese medicine of this treatment scapulohumeral periarthritis can be treated the scapulohumeral periarthritis effect, makes pain disappear, and do not recur after the further consultation, and without any side effects, its cure rate reaches 95%.

Claims (2)

1. Chinese medicine for the treatment of scapulohumeral periarthritis is characterized in that: get Flos Carthami 30 grams, Radix Angelicae Sinensis 30 grams, Retinervus Luffae Fructus 30 grams, Rhizoma Anemones Raddeanae 50 grams, the Cortex Eucommiae 40 grams, Rhizoma Et Radix Notopterygii 40 grams, Olibanum 25 grams, Myrrha 25 grams, the degree of accuracy of the dose of this medicine be each medicine ± 10%.
2. Chinese medicine for the treatment of scapulohumeral periarthritis, the feature of its processing technology is: said medicine was soaked 30 minutes with unrooted water 1500 grams, after medicine is pulled out and dried in the shade, pulverize and be powdery, every pair of medicinal 60 degree Chinese liquor, 150 grams are mixed thoroughly and are got final product.
CN2010105037593A 2010-10-08 2010-10-08 Traditional Chinese medicine for treating scapulohumeral periarthritis Pending CN101983652A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN2010105037593A CN101983652A (en) 2010-10-08 2010-10-08 Traditional Chinese medicine for treating scapulohumeral periarthritis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN2010105037593A CN101983652A (en) 2010-10-08 2010-10-08 Traditional Chinese medicine for treating scapulohumeral periarthritis

Publications (1)

Publication Number Publication Date
CN101983652A true CN101983652A (en) 2011-03-09

Family

ID=43640815

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2010105037593A Pending CN101983652A (en) 2010-10-08 2010-10-08 Traditional Chinese medicine for treating scapulohumeral periarthritis

Country Status (1)

Country Link
CN (1) CN101983652A (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102697928A (en) * 2012-06-14 2012-10-03 漳州片仔癀药业股份有限公司 Preparation method for medicine composition for treating traumatic injury
CN102716239A (en) * 2012-06-14 2012-10-10 漳州片仔癀药业股份有限公司 Pharmaceutical composite for treating traumatic injury
CN105535338A (en) * 2015-12-29 2016-05-04 吕富冉 Traditional Chinese medicine preparation for treating senile scapulohumeral periarthritis and nursing method
CN106822824A (en) * 2015-12-07 2017-06-13 陈琼芳 It is a kind of to lie prostrate the dietotherapy side for controlling scapulohumeral periarthritis

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102697928A (en) * 2012-06-14 2012-10-03 漳州片仔癀药业股份有限公司 Preparation method for medicine composition for treating traumatic injury
CN102716239A (en) * 2012-06-14 2012-10-10 漳州片仔癀药业股份有限公司 Pharmaceutical composite for treating traumatic injury
CN102697928B (en) * 2012-06-14 2014-06-11 漳州片仔癀药业股份有限公司 Preparation method for medicine composition for treating traumatic injury
CN106822824A (en) * 2015-12-07 2017-06-13 陈琼芳 It is a kind of to lie prostrate the dietotherapy side for controlling scapulohumeral periarthritis
CN105535338A (en) * 2015-12-29 2016-05-04 吕富冉 Traditional Chinese medicine preparation for treating senile scapulohumeral periarthritis and nursing method

Similar Documents

Publication Publication Date Title
CN101972413B (en) Traditional Chinese medicine for treating facial paralysis
CN103393895B (en) Bone-setting traditional Chinese medicine decoction and preparation method thereof
CN101961449B (en) Traditional Chinese medicine for treating tinea corporis
CN104984191B (en) Treat the Chinese medicine composition of acute lumbar muscle sprain
CN102008610B (en) Traditional Chinese medicine composition for curing hyperosteogeny
CN101983652A (en) Traditional Chinese medicine for treating scapulohumeral periarthritis
CN101983644A (en) Medicament for treating sequelae of apoplexy
CN102078472A (en) Medicament for treating verruca wart
CN101850026B (en) Hot compress medicament package for treating lumbar intervertebral disc protrusion, lumbar muscle strain and soft tissue injury
CN103211886A (en) Medicament for treating rheumatic arthritis
CN102526385B (en) Medicament for treating climacteric syndrome
CN101983682A (en) Medicament for treating female climacteric metancholia
CN101810668A (en) Toxin drawing plaster
CN101961455A (en) Traditional Chinese medicine for treating chronic colitis disease
CN104474405A (en) Traditional Chinese medicine composition for treating chloasma
CN104258326A (en) Traditional Chinese medicine used for treating scapulohumeral periarthritis
CN104189273A (en) Traditional Chinese medicine used for treating thrombophlebitis
CN103768290A (en) Traditional Chinese medicine composition for treating synovitis and preparation method thereof
CN1322886C (en) Plaster for treating pain and prpearation thereof
CN103127274A (en) All-season burn and scald medicine for seasons
CN107158126A (en) A kind of anti-inflammatory analgetic composition
CN102343081A (en) Moxibustion tool of pure Chinese medicinal preparation for treating bone aching and pure Chinese medicinal preparation for treating bone aching
CN101940652A (en) Chinese medicinal liniment for treating psoriasis, multiple kinds of stubborn dermatitis and pruritus
CN101983712A (en) Novel medicament for treating coronary heart disease
CN101983681A (en) Medicament for treating abnormal leucorrhea

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20110309